Page last updated: 2024-10-30

lansoprazole and Catarrh

lansoprazole has been researched along with Catarrh in 1 studies

Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.

Catarrh: Inflammation of a mucous membrane with increased flow of mucous in humans or animals. Catarrh is used mostly in a historical context.

Research Excerpts

ExcerptRelevanceReference
"One hundred patients with COPD (mean age +/- SD 74."2.74A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients. ( Arai, H; Araya, J; Asamura, T; Kuwano, K; Nakayama, K; Ohrui, T; Sasaki, T; Yamaya, M; Yasuda, H; Yoshida, M, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sasaki, T1
Nakayama, K1
Yasuda, H1
Yoshida, M1
Asamura, T1
Ohrui, T1
Arai, H1
Araya, J1
Kuwano, K1
Yamaya, M1

Trials

1 trial available for lansoprazole and Catarrh

ArticleYear
A randomized, single-blind study of lansoprazole for the prevention of exacerbations of chronic obstructive pulmonary disease in older patients.
    Journal of the American Geriatrics Society, 2009, Volume: 57, Issue:8

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Anti-Infective Agents; Common Cold; Female; Humans; J

2009